Insider’s View: Deciphering Upstream Bio Inc (UPB)’s Financial Health Through Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

The price of Upstream Bio Inc (NASDAQ: UPB) closed at $15.31 in the last session, up 0.79% from day before closing price of $15.19. In other words, the price has increased by $0.79 from its previous closing price. On the day, 0.57 million shares were traded. UPB stock price reached its highest trading level at $16.15 during the session, while it also had its lowest trading level at $15.015.

Ratios:

We take a closer look at UPB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 47.43 and its Current Ratio is at 47.43. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On November 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $75.Piper Sandler initiated its Overweight rating on November 05, 2024, with a $75 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 15 ’24 when Chimovits Erez bought 825,000 shares for $17.00 per share. The transaction valued at 14,025,000 led to the insider holds 4,554,873 shares of the business.

ORBIMED ADVISORS LLC bought 825,000 shares of UPB for $14,025,000 on Oct 15 ’24. The Director now owns 4,554,873 shares after completing the transaction at $17.00 per share. On Oct 15 ’24, another insider, AI Upstream LLC, who serves as the 10% Owner of the company, bought 1,175,000 shares for $17.00 each. As a result, the insider paid 19,975,000 and bolstered with 1,175,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UPB now has a Market Capitalization of 823581568 and an Enterprise Value of 393901600. Its current Enterprise Value per Revenue stands at 171.56 whereas that against EBITDA is -4.162.

Stock Price History:

Over the past 52 weeks, UPB has reached a high of $29.46, while it has fallen to a 52-week low of $5.14. The 50-Day Moving Average of the stock is 36.94%, while the 200-Day Moving Average is calculated to be 15.10%.

Shares Statistics:

According to the various share statistics, UPB traded on average about 443.95K shares per day over the past 3-months and 554860 shares per day over the past 10 days. A total of 53.64M shares are outstanding, with a floating share count of 19.37M. Insiders hold about 63.99% of the company’s shares, while institutions hold 48.34% stake in the company. Shares short for UPB as of 1752537600 were 3781146 with a Short Ratio of 8.52, compared to 1749772800 on 3610360. Therefore, it implies a Short% of Shares Outstanding of 3781146 and a Short% of Float of 12.72.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.